WO1993000898A1 - Pharmaceutical formulation of a beta-lactam antibiotic and clavulanic acid or a water-soluble salt thereof - Google Patents
Pharmaceutical formulation of a beta-lactam antibiotic and clavulanic acid or a water-soluble salt thereof Download PDFInfo
- Publication number
- WO1993000898A1 WO1993000898A1 PCT/GB1992/001207 GB9201207W WO9300898A1 WO 1993000898 A1 WO1993000898 A1 WO 1993000898A1 GB 9201207 W GB9201207 W GB 9201207W WO 9300898 A1 WO9300898 A1 WO 9300898A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- pharmaceutical formulation
- acid
- salt
- formulation according
- dicarboxylic acid
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/429—Thiazoles condensed with heterocyclic ring systems
- A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
Abstract
Description
Claims
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP92914294A EP0593573A1 (en) | 1991-07-11 | 1992-07-03 | Pharmaceutical formulation of a beta-lactam antibiotic and clavulanic acid or a water-soluble salt thereof |
JP5502080A JPH06508844A (en) | 1991-07-11 | 1992-07-03 | Pharmaceutical formulations of beta-lactam antibiotics and clavulanic acid or its water-soluble salts |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB919114950A GB9114950D0 (en) | 1991-07-11 | 1991-07-11 | Pharmaceutical formulation |
GB9114950.0 | 1991-07-11 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO1993000898A1 true WO1993000898A1 (en) | 1993-01-21 |
Family
ID=10698173
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/GB1992/001207 WO1993000898A1 (en) | 1991-07-11 | 1992-07-03 | Pharmaceutical formulation of a beta-lactam antibiotic and clavulanic acid or a water-soluble salt thereof |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP0593573A1 (en) |
JP (1) | JPH06508844A (en) |
AU (1) | AU2230692A (en) |
GB (1) | GB9114950D0 (en) |
WO (1) | WO1993000898A1 (en) |
Cited By (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1998024414A1 (en) * | 1996-12-05 | 1998-06-11 | American Home Products Corporation | Pharmaceutical suspension systems |
WO1998036732A2 (en) * | 1997-02-21 | 1998-08-27 | Lindopharm Gmbh | Combination preparation for orally administered antibiotics |
WO2000010527A1 (en) * | 1998-08-24 | 2000-03-02 | The Procter & Gamble Company | Oral mucoadhesive compositions containing gastrointestinal actives |
US6660299B2 (en) | 1999-04-13 | 2003-12-09 | Beecham Pharmaceuticals Limited | Modified release pharmaceutical formulation comprising amoxycillin |
US6726908B2 (en) | 1995-09-07 | 2004-04-27 | Smithkline Beecham P.L.C. | Pharmaceutical formulation |
US6746692B2 (en) | 1999-04-13 | 2004-06-08 | Beecham Pharmaceuticals (Pte) Limited | Modified release pharmaceutical formulation comprising amoxycillin |
US6756057B2 (en) | 2000-10-12 | 2004-06-29 | Beecham Pharmaceuticals (Pte) Limited | Amoxicillin and potassium clavulanate dosage form |
US6783773B1 (en) | 1999-04-13 | 2004-08-31 | Beecham Pharmaceuticals (Pte) Limited | Composition comprising amoxicillin and potassium clavulanate |
US7011849B2 (en) | 2000-10-12 | 2006-03-14 | Beecham Pharmaceuticals (Pte) Limited | Second release phase formulation |
US20130028844A1 (en) * | 2010-01-29 | 2013-01-31 | Mahmut Bilgic | Preparations for effervescent formulations comprising cephalosporin and uses thereof |
US9260375B2 (en) | 2005-09-22 | 2016-02-16 | Meiji Seika Kaisha, Ltd. | Metallo-β-lactamase inhibitors |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2011142730A1 (en) | 2010-05-14 | 2011-11-17 | Mahmut Bilgic | Pharmaceutical composition comprising cefixime and clavulanic acid derivative compound |
EP2568959A2 (en) | 2010-05-14 | 2013-03-20 | Mahmut Bilgic | Formulations comprising a third generation cephalosporin and clavulanic acid |
WO2011152808A1 (en) | 2010-06-03 | 2011-12-08 | Mahmut Bilgic | Formulation comprising cefpodoxime proxetil and clavulanic acid |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0080862A1 (en) * | 1981-12-02 | 1983-06-08 | Beecham Group Plc | Pharmaceutical formulation comprising beta-lactam antibiotics |
WO1991015197A1 (en) * | 1990-04-07 | 1991-10-17 | Beecham Group Plc | Pharmaceutical formulation |
-
1991
- 1991-07-11 GB GB919114950A patent/GB9114950D0/en active Pending
-
1992
- 1992-07-03 AU AU22306/92A patent/AU2230692A/en not_active Abandoned
- 1992-07-03 WO PCT/GB1992/001207 patent/WO1993000898A1/en not_active Application Discontinuation
- 1992-07-03 EP EP92914294A patent/EP0593573A1/en not_active Withdrawn
- 1992-07-03 JP JP5502080A patent/JPH06508844A/en active Pending
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0080862A1 (en) * | 1981-12-02 | 1983-06-08 | Beecham Group Plc | Pharmaceutical formulation comprising beta-lactam antibiotics |
WO1991015197A1 (en) * | 1990-04-07 | 1991-10-17 | Beecham Group Plc | Pharmaceutical formulation |
Cited By (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6726908B2 (en) | 1995-09-07 | 2004-04-27 | Smithkline Beecham P.L.C. | Pharmaceutical formulation |
WO1998024414A1 (en) * | 1996-12-05 | 1998-06-11 | American Home Products Corporation | Pharmaceutical suspension systems |
WO1998036732A2 (en) * | 1997-02-21 | 1998-08-27 | Lindopharm Gmbh | Combination preparation for orally administered antibiotics |
WO1998036732A3 (en) * | 1997-02-21 | 1998-10-22 | Glf Galenik Labor Gmbh | Combination preparation for orally administered antibiotics |
WO2000010527A1 (en) * | 1998-08-24 | 2000-03-02 | The Procter & Gamble Company | Oral mucoadhesive compositions containing gastrointestinal actives |
US6783773B1 (en) | 1999-04-13 | 2004-08-31 | Beecham Pharmaceuticals (Pte) Limited | Composition comprising amoxicillin and potassium clavulanate |
US6746692B2 (en) | 1999-04-13 | 2004-06-08 | Beecham Pharmaceuticals (Pte) Limited | Modified release pharmaceutical formulation comprising amoxycillin |
US6660299B2 (en) | 1999-04-13 | 2003-12-09 | Beecham Pharmaceuticals Limited | Modified release pharmaceutical formulation comprising amoxycillin |
US6878386B1 (en) | 1999-04-13 | 2005-04-12 | Beecham Pharmaceuticals (Pte) Limited | Method of treating a bacterial infection comprising amoxycillin and potassium clavulanate |
US7217430B2 (en) | 1999-04-13 | 2007-05-15 | Beecham Pharmaceuticals (Pte) Limited | Compositions and methods of treatment comprising amoxicillin and potassium clavulanate with xanthan |
US7250176B1 (en) | 1999-04-13 | 2007-07-31 | Beecham Pharmaceuticals (Pte) Limited | Method of treating a bacterial infection |
US6756057B2 (en) | 2000-10-12 | 2004-06-29 | Beecham Pharmaceuticals (Pte) Limited | Amoxicillin and potassium clavulanate dosage form |
US7011849B2 (en) | 2000-10-12 | 2006-03-14 | Beecham Pharmaceuticals (Pte) Limited | Second release phase formulation |
US9260375B2 (en) | 2005-09-22 | 2016-02-16 | Meiji Seika Kaisha, Ltd. | Metallo-β-lactamase inhibitors |
US20130028844A1 (en) * | 2010-01-29 | 2013-01-31 | Mahmut Bilgic | Preparations for effervescent formulations comprising cephalosporin and uses thereof |
US8956653B2 (en) * | 2010-01-29 | 2015-02-17 | Mahmut Bilgic | Preparations for effervescent formulations comprising cephalosporin and uses thereof |
US9603794B2 (en) | 2010-01-29 | 2017-03-28 | Mahmut Bilgic | Preparations of effervescent formulations comprising cephalosporin and uses thereof |
Also Published As
Publication number | Publication date |
---|---|
GB9114950D0 (en) | 1991-08-28 |
EP0593573A1 (en) | 1994-04-27 |
JPH06508844A (en) | 1994-10-06 |
AU2230692A (en) | 1993-02-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU722657B2 (en) | Use of a combination of amoxycillin and clavulanate in the manufacture of a medicament for the treatment drug-resistant streptococcus pneumonia | |
EP0862431B1 (en) | Use of a paediatric pharmaceutical formulation comprising amoxycillin and clavulanate | |
US4676984A (en) | Rehydratable antacid composition | |
WO1993000898A1 (en) | Pharmaceutical formulation of a beta-lactam antibiotic and clavulanic acid or a water-soluble salt thereof | |
EP0825860B1 (en) | Use of a composition comprising amoxycillin and clavulanic acid for the manufacture of a medicament for the treatment of bacterial infections in paediatric patients | |
AU762840B2 (en) | Pharmaceutical suspension formulation comprising amoxycillin, clavulanic acid and cellulose | |
US6066629A (en) | Storage stable amoxycillin and clavulanate suspension composition | |
WO2001045667A2 (en) | Water-soluble powders for oral solution and use thereof | |
US4272542A (en) | Use of di-sodium and di-potassium salts of dicarboxylic amino acids and tri- or di-sodium or potassium phosphate tartrate or citrate to improve the taste of in vivo hydrolysable esters of α-amino penicillins and cephalosporins | |
EP0178895B1 (en) | Fluidized and rehydratable magaldrate compositions | |
US20020099044A1 (en) | Composition comprising amoxycillin and clavulanic acid | |
WO2000050036A1 (en) | Storage stable amoxycillin and clavulanate suspension composition | |
WO1997006798A2 (en) | Pharmaceutical formulations | |
EP0008178A2 (en) | Powder, process for its preparation, container holding it, and syrup comprising the powder reconstituted with water | |
EP0008179A2 (en) | Powder, process for its preparation, container holding it, and syrup comprising the powder reconstituted with water | |
AU4484199A (en) | Pharmaceutical formulation | |
MXPA99001807A (en) | Use of a combination of amoxycillin and clavulanate in the manufacture of a medicament for the treatment drug-resistant streptococcus pneumonia |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AU CA JP KR US |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): AT BE CH DE DK ES FR GB GR IT LU MC NL SE |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
WWE | Wipo information: entry into national phase |
Ref document number: 1992914294 Country of ref document: EP |
|
ENP | Entry into the national phase |
Ref country code: US Ref document number: 1994 185988 Date of ref document: 19940111 Kind code of ref document: A Format of ref document f/p: F |
|
WWP | Wipo information: published in national office |
Ref document number: 1992914294 Country of ref document: EP |
|
NENP | Non-entry into the national phase |
Ref country code: CA |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 1992914294 Country of ref document: EP |